Form EFFECT Kalaris Therapeutics,
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | April 13, 2026 4:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bitcoin Price Prediction: BTC Repeats a 2012 Streak That Came Before a 2,000% Run as DigiTap Targets 100x Gains
- PrismML Brings 1-Bit Bonsai Models to AI Smart Glasses Powered by Snapdragon
- One Year Post Strategic Merger with Sidecar Group, Equus Growth Advisors Reflects on Annual Achievements
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
